EverQuote, Inc.: Form 10-K for the period ended Dec 31, 2018
Filed with the SEC on Apr 1, 2019 and accepted by EDGAR at Apr 1, 2019, 20:34 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2018-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2018-10-01 to 2018-12-31 | $39.8m | us-gaap:Revenues |
| Cost of revenue | 3 months2018-10-01 to 2018-12-31 | $3.1m | us-gaap:CostOfRevenue |
| Cost of revenue | 12 months2018-01-01 to 2018-12-31 | $11.7m | us-gaap:CostOfRevenue |
| Research and development | 12 months2018-01-01 to 2018-12-31 | $14.2m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2018-10-01 to 2018-12-31 | −$7.1m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2018-01-01 to 2018-12-31 | −$13.9m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2018-01-01 to 2018-12-31 | $199.0k | us-gaap:InterestExpense |
| Income tax | 12 months2018-01-01 to 2018-12-31 | $0 | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2018-10-01 to 2018-12-31 | −$6.9m | us-gaap:NetIncomeLoss |
| Net income | 12 months2018-01-01 to 2018-12-31 | −$13.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2018-01-01 to 2018-12-31 | −$3.03 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2018-01-01 to 2018-12-31 | −$1.9m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2018-01-01 to 2018-12-31 | $3.7m | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | At period end2018-12-31 | $41.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2018-12-31 | $60.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2018-12-31 | $65.7m | us-gaap:Assets |
| Current liabilities | At period end2018-12-31 | $21.4m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2018-12-31 | $22.6m | us-gaap:Liabilities |
| Shareholders' equity | At period end2018-12-31 | $43.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-19-094588. Last ingested by Listed: Nov 10, 2026, 04:46 ET. Listed shows no prices and gives no investment advice.